Stryker has launched Mako 4 SmartRobotics in India, the fourth generation of its Mako robotic-arm assisted technology, aimed at enhancing joint replacement procedures.
Designed to support a more integrated clinical and operational experience, Mako 4 combines patient-specific planning, robotic technology and haptic guidance in a single system across three applications: Mako Total Knee, Mako Partial Knee and Mako Total Hip, including advanced primary and revision procedures.
Building on more than two decades of innovation, Mako 4 pairs 3D CT-based planning with AccuStop haptic technology to help surgeons plan and execute procedures based on a patient’s individual anatomy. The platform also provides real-time intraoperative guidance, helping deliver greater precision and control during joint replacement procedures.
Aman Rishi, vice president and general manager,India, Stryker, said India’s healthcare landscape is evolving rapidly, with growing demand for advanced treatments that support active, healthy lives.
“At Stryker, we are committed to bringing innovation that empowers surgeons and supports the future of healthcare in the country. We’re proud to bring Mako 4 to India, helping raise the standard of care and expand access for joint replacement patients nationwide,” he said.
Stryker Announces Leadership Succession
Separately, Stryker has announced a planned leadership transition. Kevin Lobo will become Executive Chair of the company’s Board of Directors, effective January 1, 2027.
Spencer Stiles, currently President and Chief Operating Officer of Stryker, will succeed Lobo as Chief Executive Officer and will join the company’s Board of Directors.
Lobo said, “The Board and I have worked closely on a succession plan, and with our strong foundation in place, now is the right time for this leadership transition. I look forward to working with Spencer to ensure a smooth transition and to continuing to support Stryker as Executive Chair of the Board.”
On being appointed as Stryker’s next CEO, Stiles said, “Kevin has built an extraordinary legacy and a strong foundation for the future, which I am excited to build upon as we continue executing our strategy, driving growth and advancing our mission to make healthcare better.”
Sheri McCoy, Lead Independent Director of Stryker’s Board of Directors, said the appointment followed a comprehensive, long-term succession planning process.
L-R: Spencer Stiles and Kevin Lobo
Stryker’s Presence in India
Stryker expanded its research and development presence in India last year with the opening of a 140,000-square-foot facility in Whitefield, Bengaluru. The facility complements the company’s existing 220,000-square-foot R&D campus in Gurugram.
The Bengaluru facility brings together cross-functional teams and lab infrastructure focused on areas including robotics, artificial intelligence, digital innovation and product security.
